The effect of cholinergic and adrenergic blockage on basal and pentagastrin-induced acid secretion.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000328:Adult; D001285:Atropine / Q000494:pharmacology*; D003864:Depression, Chemical; D004381:Duodenal Ulcer / Q000503:physiopathology*; D005745:Gastric Acidity Determination; D005750:Gastric Juice / Q000378:metabolism*; D005753:Gastric Mucosa / Q000378:metabolism*; D006801:Humans; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D010455:Peptides / Q000008:administration & dosage*; D011433:Propranolol / Q000494:pharmacology*; D012636:Secretory Rate; D013997:Time Factors
D000319:Adrenergic beta-Antagonists; D010455:Peptides; D001285:Atropine; D011433:Propranolol